Alon Chappleboim
Papers
2
Total Citations
16
H-Index
2
About
Alon Chappleboim is a researcher whose work has made meaningful contributions to the field of molecular diagnostics, with a particular focus on high-throughput SARS-CoV-2 detection methodologies during the COVID-19 pandemic. His research centers on developing innovative, scalable testing protocols that address critical bottlenecks in viral diagnostics, especially the dependency on RNA extraction — a step that proved to be a significant logistical constraint during the global health crisis. Chappleboim's most recognized work includes the development of ApharSeq, an extraction-free early-pooling protocol designed for massively multiplexed SARS-CoV-2 detection, which has garnered 5 citations. Building on this foundation, his 2021 study introducing early sample tagging and pooling to enable simultaneous SARS-CoV-2 detection and variant sequencing has attracted 11 citations, reflecting its timeliness and technical significance. Together, these contributions demonstrate a consistent drive to improve testing capacity and genomic surveillance simultaneously, offering practical solutions applicable at scale. His work is particularly notable for bridging the gap between diagnostic efficiency and genomic epidemiology, equipping public health systems with tools better suited to rapidly evolving viral outbreaks.
Research Focus
Key Achievements
Top Papers
- 1
- 2